Patients and Researchers
to Drive Personalized Medicine
Genterpret empowers patients with access to their genetic data
while providing researchers with powerful data ready to provide insights.
What does your DNA say about you?
Get Access to Your Genetic Data
Thousands of scientific articles have been published linking genetics to traits and disease. The genetic information stored in your DNA sheds light on your ancestry and traits, from dimples to medical conditions. Take the first step in learning what your DNA says about you with Genterpret.
Thanks to people like you, many genetic variants have been associated with diseases, enabling the development of new drugs. But there are still thousands of connections to be made.
Your data will help doctors personalize treatments for better results and will help researchers to develop better drugs.
Security is in Our DNA
Your privacy and the security of your data is our top priority. That's why we store your data in secure HIPAA-compliant environment. We use 256-bit AES (Advanced Encryption Standard), the same system the government uses for sensitive information. Before your data is used in research, we remove your personal information and make it anonymous.
INTERESTED IN PARTICIPATING?
If you are interested in learning more, fill out the form below.
Accelerate your research. Here's how.
Connect with Committed Patients
Larger Samples Sizes = Better Insights. By leveraging our relationships with individual patients, patient advocacy groups, and patient communities, we connect you to the number of patients you need to make the discoveries that matter.
Link Genetics to Drug Response
Genetic data has the power to improve drug development, efficacy, and safety. For pharmaceutical companies, this means better drugs and a larger market. With our data, you can conduct better research at lower costs. It's just that simple.
Make More Informed Decisions
At Genterpret, we help you complete patient-centric campaigns by aggregating and delivering high-quality genetic and clinical data. We work with patients. You receive de-identified data that’s ready to provide insights.
WHO WE ARE
Daniel Lieber, PhD
Dr. Daniel Lieber earned an AB from Princeton University and a PhD in Systems Biology from Harvard University. Dr. Lieber worked with Dr. Vamsi Mootha at Massachusetts General Hospital to develop new computational pipelines to identify and prioritize mutations that lead to neurological disorders, providing new diagnoses in several of the cases. His research has been published in
Science Translational Medicine
Steve Hershman, PhD
Dr. Steve Hershman earned BA, MS and MSE degrees from the University of Pennsylvania and a PhD from Harvard University. Under the guidance of Dr. Vamsi Mootha at Massachusetts General Hospital, Dr. Hershman developed new analytic tools to identify and prioritize mutations that lead to disease, providing new diagnoses in several cases of mitochondrial disease. His research has been published in
Science Translational Medicine
Connect with us!
483 Broadway, 2nd Floor New York, NY 10013
Have a question? Interested in running a study?
Supporters & Press